Novartis Pharma Ag
USPTO Trademark & Patent Filings
Trademark applications and grants for Novartis Pharma Ag. Novartis Pharma Ag has 32 trademark applications. The latest application filed is for "a symbol or image mark"
- Company Aliases
- NOVARTIS PHARMA AG
- ag pharma novartis
- NOVARTIS PHARMA AG - BASEL CH
- NOVARTIS PHARMA AG - Basel CH
- Novartis Pharma AG - Basel CH
Trademarks Patents
| Patent Application | Date |
|---|---|
| IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF 20220213184 - 17/373426 Arnott; David P. ; et al. | 2022-07-07 |
| IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF 20220213183 - 17/373414 Arnott; David P ; et al. | 2022-07-07 |
| IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF 20220204606 - 17/373422 Arnott; David P ; et al. | 2022-06-30 |
| IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF 20200385452 - 16/700823 ARNOTT; David P. ; et al. | 2020-12-10 |
| IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF 20200377585 - 16/784173 ARNOTT; David P. ; et al. | 2020-12-03 |
| Computer-implemented methods of determining protein viscosity 10,762,980 - 14/891,906 Trout , et al. Sep | 2020-09-01 |
| Computer-implemented methods of determining protein viscosity 10,762,980 - 14/891,906 Trout , et al. Sep | 2020-09-01 |
| Methods for treating neovascular age-related macular degeneration 10,035,850 - 14/934,731 Gekkieva , et al. July 31, 2 | 2018-07-31 |
| mTOR/JAK inhibitor combination therapy 9,993,480 - 13/399,274 Vannucchi , et al. June 12, 2 | 2018-06-12 |
| Anti-BAFFR antibody formulations 9,458,240 - 13/991,984 Cosenza , et al. October 4, 2 | 2016-10-04 |
| SEC | 0001030617 | NOVARTIS PHARMA AG |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 